Biocore9 Femoral Head Resurfacing Component
Prosthesis, Hip, Femoral, Resurfacing. 510(k) K201219, from Biocore9, LLC (Whippany, NJ). Product code KXA, class 2.
As of Nov 17, 2026, K201219 is an FDA 510(k) held by Biocore9, LLC, substantially equivalent on Jan 19, 2021 after 258 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Jan 19, 2021
- Review time: 258 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Biocore9 Femoral Resurfacing Head Component, used with cement, is indicated for the treatment of painful hip arthritis due to post-traumatic arthritis, osteoarthritis, or rheumatoid arthritis, as well as painful hip arthroplasty when sufficient femoral head and neck stock exist to stabilize a resurfacing femoral head.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Modified New Jersey Femoral Hip Resurfacing ComponK904870 · Endotec, Inc. · May 23, 1991
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 6, 2020
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3400
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files